Refractory Hypoglycemia in a 2-Month Old Female

Case Report

Austin Pediatr. 2017; 4(1): 1051.

Refractory Hypoglycemia in a 2-Month Old Female

Brunson C¹ and Chadha T2,3*

¹Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, USA

²Department of Pediatrics, Wolfson Children’s Hospital, Jacksonville, USA

³Department of Pediatrics, University of Florida College of Medicine, Jacksonville, USA

*Corresponding author: Tanya Chadha, Department of Pediatrics, Wolfson Children’s Hospital, Jacksonville, USA

Received: April 03, 2017; Accepted: April 18, 2017; Published: April 25, 2017

Abstract

In this case report, we describe a rare cause of persistent hypoglycemia in a young infant. The case briefly highlights for the pediatric trainee the broad differential diagnosis for hypoglycemia, a commonly encountered laboratory abnormality in the young infant population and the importance of history and physical exam in arriving at a final diagnosis.

Keywords: Hypoglycemia; Infants; Growth hormone; Hypopituitarism; Sepsis

Case Presentation

A 2-month old full term Hispanic female presented to the emergency room with an initial complaint of no bowel movement for the past 24 hours. On further questioning the parents also state that the patient had a decrease in the amount of feeding overnight into the morning of presentation. Her parents deny any fever, irritability, vomiting or diarrhea and don’t endorse any toxic ingestion or recent trauma. The patient’s past medical history is significant for neonatal intensive care unit admission at birth for observation secondary to apneic episodes and hypoglycemia briefly requiring dextrose containing intravenous fluids to normalize her blood glucose levels.

On presentation to the emergency room she was found to be lethargic with no other significant findings on physical exam. Of note, she was found to have dysmorphic facies. Vital signs were as follows: temperature 97 degrees Fahrenheit, heart rate 139 beats per minute, respiratory rate 22 breaths per minute, blood pressure 103/48 mmHg and oxygen saturation 100% on room air. The patient’s lethargy prompted a dextrose stick which was <35mg/dL for which she received an IV dextrose bolus with transient improvement in her mental status. However, she continued to have episodes of lethargy associated with significant hypoglycemia that required IV dextrose for correction. She was transferred to the pediatric intensive care unit for further evaluation.

The patient’s initial laboratory evaluation was significant for glucose level of 20mg/dl with otherwise normal serum electrolytes and normal liver function studies. With low suspicion of ingestion based on history, sepsis was considered the likely source of hypoglycemia and thus a work-up was completed and broad spectrum antibiotics were started. The white blood cell count was normal and urinalysis was negative for leukocyte esterase, nitrites and ketones. Blood, urine and cerebrospinal fluid cultures were all subsequently found to be negative. With ongoing hypoglycemia requiring significant intravenous dextrose supplementation, development of abnormal movements concerning for seizures and dysmorphic faces noted upon presentation, multiple subspecialists were consulted for further evaluation and a number of laboratory and imaging diagnostics were pursued. Video electroencephalography was normal. A magnetic resonance imaging study of the patient’s brain revealed an ectopic posterior pituitary gland. A chromosomal evaluation was found to be abnormal. Laboratory investigation demonstrated a low growth hormone level of 0.87ng/mL (normal 5-40ng/mL), a normal insulinlike growth factor-1 level of 25ng/ml (normal 17-185 ng/mL), a low free thyroxine level of 0.73ng/dL (normal 0.9 -1.9ng/dL) and a low cortisol level of 3.7mcg/dL (normal 5-14mcg/dL).

The patient was started on supplementary growth hormone injections and hydrocortisone replacement with improvement in her dextrose levels. She was able to be weaned off of intravenous fluids and was able to maintain her dextrose levels with just oral feeding. The patient was discharged home on genotropin; hydrocortisone and synthroid with close follow up with endocrine, neurology and genetics. The final diagnosis was pan-hypopituitarism secondary to 18p deletion syndrome.

Discussion

18p deletion syndrome is a rare genetic syndrome first described in the literature in 1963 by de Grouchy and colleagues [1]. The syndrome is characterized by deletion of the whole or part of the short arm of the chromosome with worsening clinical symptoms the closer the deletion is to the centromere [2]. There have been many case reports since the early 1960s which report a constellation of symptoms associated with this syndrome which include cognitive impairments, small stature, minor facial dysmorphism, ptosis, strabismus, holoprosencephaly, speech and language difficulties, pituitary abnormalities and IgA deficiency. In particular the pituitary abnormalities can include a hypo plastic pituitary gland, an absent or ectopic posterior pituitary (Figure 1), complete absence of the pituitary gland or a hypo plastic pituitary stalk [1]. Our patient’s physical exam and diagnostic work up revealed dysmorphic facies and an ectopic posterior pituitary with chromosomal analysis confirming the diagnosis of 18p deletion syndrome.